The Bioavailability of Mycoprotein

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04233411

Enrollment

Registered

2020-01-18

Start date

2016-01-31

Completion date

2018-01-31

Last updated

2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Availability of Mycoprotein

Brief summary

To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.

Interventions

OTHERMycoprotein ingestion

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

BASIC_SCIENCE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

MALE

Age

18 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy and aged 18-40 y * BMI between 18 and 30

Exclusion criteria

* On medication * Family history of metabolic disease * Diagnosed with any metabolic or cardiovascular conditions * BMI \< 18 or \> 30

Design outcomes

Primary

Measure	Time frame
Plasma total amino acid concentrations	4 hours

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026